In all, we suggest that alterations in the expression of miR-135a-5p and membranous and cytoplasmic pY397-FAK during thyroid malignant transformation can qualitatively modify malignant cells towards more aggressive phenotypes and facilitate PTC to dedifferentiate into ATC via disruption of the mentioned regulatory pathways. Here, PTK2 is linked to thyroid gland disorder.